文献速递脊柱关节炎其他结缔组织病

银屑病关节炎患者对中性粒细胞弹性蛋白酶调节能力降低

Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究比较了银屑病(PsO)伴与不伴银屑病关节炎(PsA)患者表皮和血清中中性粒细胞弹性蛋白酶(NE)与弹性蛋白酶抑制因子elafin的表达。结果显示PsA患者elafin表达降低,NE与elafin比值及NE与分泌型白细胞蛋白酶抑制剂比值在PsA中显著改变,提示PsA患者调节中性粒细胞活性的能力存在差异。

要点

  • PsA患者皮肤和血液中elafin表达较单纯斑块型PsO患者降低。
  • NE与elafin比值在PsO与PsA患者间存在显著差异。
  • PsA患者NE与分泌型白细胞蛋白酶抑制剂比值高于PsO、健康对照及其他关节炎患者。

核心结论

  • PsA患者在皮肤和血液中均显示NE抑制因子表达降低,提示其调节中性粒细胞活性的能力可能存在差异。

研究设计与样本

  • 在匹配的表皮样本和血清中分析PsO、PsA患者及健康对照的NE和elafin蛋白表达,并在独立PsA和关节炎队列中验证。

主要发现

  • NE与elafin比值在PsO和PsA患者间差异显著。
  • PsA样本中elafin表达较斑块型PsO患者降低。
  • PsA患者NE与分泌型白细胞蛋白酶抑制剂比值高于无PsA的PsO患者、健康对照及其他关节炎患者。

临床怎么用

  • NE与elafin比值及NE与分泌型白细胞蛋白酶抑制剂比值可能有助于区分PsO患者中是否伴发PsA。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Identifying which patients with psoriasis (PsO) may develop PsA is a research priority. We have previously shown that elafin, along with IL-36γ, are excellent cutaneous biomarkers for PsO. The protease inhibitor elafin and its target protease, neutrophil elastase (NE), can be detected in both serum and epidermal samples. Our aims were to assess whether known PsO biomarkers are expressed differentially in patients affected by plaque PsO with and without PsA. METHODS: Protein expression of NE and elafin were analysed in matched epidermal samples and serum of PsO, PsA patients and healthy controls. Findings were validated in independent PsA and arthritis cohorts. RESULTS: The ratio between NE and elafin differed significantly between PsO and PsA patients. Expression of elafin was reduced in PsA samples as compared with plaque PsO patients. The ratio of NE to secretory leucocyte protease inhibitor was also increased in PsA as compared with PsO patients with no PsA, healthy controls and other arthritis patients. CONCLUSIONS: PsA patients show a reduced NE inhibitor expression in both the skin and blood compartment compared with those with plaque PsO only. This may suggest differences in the ability to regulated neutrophil activity in PsA patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Macleod T, Dubash SR, Hyde I, et al. Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase. Rheumatology (Oxford). 2026. PMID: 42484178. doi:10.1093/rheumatology/keag369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。